MeSH term
Frequency | Condition_Probility | Animals | 23 | 0.0 |
Endothelial Growth Factors/pharmacology | 2 | 1.0 |
Female | 14 | 0.0 |
Humans | 48 | 0.0 |
Lymphokines/pharmacology | 2 | 1.0 |
Mice | 15 | 0.0 |
Mice, Nude | 2 | 0.0 |
Rats | 2 | 0.0 |
Receptors, Vascular Endothelial Growth Factor | 20 | 3.0 |
Research Support, Non-U.S. Gov't | 29 | 0.0 |
Vascular Endothelial Growth Factor A | 24 | 0.0 |
Vascular Endothelial Growth Factor Receptor-1 | 18 | 8.0 |
Vascular Endothelial Growth Factors | 25 | 0.0 |
Cell Division | 3 | 0.0 |
Biopsy | 3 | 0.0 |
English Abstract | 4 | 0.0 |
Multigene Family | 2 | 0.0 |
Tumor Cells, Cultured | 11 | 0.0 |
Adult | 8 | 0.0 |
Aged | 5 | 0.0 |
Male | 11 | 0.0 |
Middle Aged | 6 | 0.0 |
Prognosis | 3 | 0.0 |
Survival Analysis | 4 | 0.0 |
Cell Division/physiology | 2 | 0.0 |
Endothelial Growth Factors/physiology | 2 | 3.0 |
Lymphokines/physiology | 2 | 2.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Endothelium, Vascular/cytology/metabolism | 2 | 1.0 |
*Neovascularization, Pathologic | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/*biosynthesis | 2 | 3.0 |
Receptors, Growth Factor/*biosynthesis | 2 | 8.0 |
Survival Rate | 2 | 0.0 |
Extracellular Matrix Proteins/genetics | 2 | 3.0 |
Molecular Sequence Data | 14 | 0.0 |
Muscle Proteins/genetics | 2 | 2.0 |
Research Support, U.S. Gov't, P.H.S. | 13 | 0.0 |
Cells, Cultured | 12 | 0.0 |
Endothelial Growth Factors/*metabolism | 4 | 1.0 |
Lymphokines/*metabolism | 4 | 0.0 |
Neoplasm Transplantation | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/*metabolism | 8 | 3.0 |
Receptors, Growth Factor/*metabolism | 5 | 4.0 |
*Signal Transduction | 3 | 0.0 |
Time Factors | 2 | 0.0 |
Transplantation, Heterologous | 2 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Proto-Oncogene Proteins/analysis | 2 | 1.0 |
Receptor Protein-Tyrosine Kinases/analysis | 2 | 4.0 |
Receptors, Growth Factor/analysis | 3 | 11.0 |
Binding Sites | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Solubility | 2 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Adenoviridae/genetics | 2 | 0.0 |
Amino Acid Sequence | 9 | 0.0 |
Comparative Study | 9 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 2 | 0.0 |
Receptors, Cell Surface/*metabolism | 3 | 0.0 |
Receptors, Growth Factor/metabolism | 2 | 1.0 |
Base Sequence | 9 | 0.0 |
DNA Primers | 2 | 0.0 |
Cell Line | 2 | 0.0 |
Enzyme Activation | 4 | 0.0 |
Phosphorylation/drug effects | 2 | 0.0 |
Protein Binding | 4 | 0.0 |
Receptor Protein-Tyrosine Kinases/genetics/*metabolism | 2 | 1.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 3 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/*genetics | 3 | 0.0 |
Receptors, Growth Factor/*genetics | 2 | 4.0 |
Cattle | 3 | 0.0 |
Evolution | 2 | 0.0 |
Gene Rearrangement | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Species Specificity | 3 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins/*genetics | 4 | 0.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
Sequence Alignment | 4 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Molecular Weight | 2 | 0.0 |
Acute Disease | 2 | 0.0 |
Bone Marrow/pathology | 2 | 0.0 |
Gene Expression | 5 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Vascular Endothelial Growth Factor Receptor-3 | 7 | 12.0 |
Umbilical Veins | 3 | 0.0 |
Cloning, Molecular | 6 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Chromosome Mapping | 5 | 0.0 |
*Chromosomes, Human, Pair 13 | 3 | 1.0 |
Genetic Markers | 2 | 0.0 |
*Translocation, Genetic | 2 | 0.0 |
In Situ Hybridization | 4 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Organ Specificity | 2 | 0.0 |
Phosphorylation | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Proto-Oncogene Protein c-kit | 2 | 2.0 |
Protein-Tyrosine Kinase/*genetics | 5 | 2.0 |
Receptors, Cell Surface/*genetics | 4 | 1.0 |
Cell Differentiation | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
*Chromosomes, Human, Pair 5 | 2 | 0.0 |
Genes, Structural | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
